Wellcome Sanger Institute announced that the EMBL-EBI-Sanger Postdoctoral (ESPOD) programme applications close on 27 September.

Public source

Publisher name

Public post

The EMBL-EBI–Sanger Postdoctoral (ESPOD) Programme builds on the collaborative relationship between EMBL-EBI and the Wellcome Sanger Institute, offering projects that co…

Log in to read the full post

Company

Wellcome Sanger Institute

We are a world leader in genomics research.

Industry
Research Services
Location
Hinxton, GB
Company size
1,001–5,000 employees

About Wellcome Sanger Institute

The Wellcome Sanger Institute is a world leader in genomics research. We generate and analyse data at a scale not easily possible elsewhere. We apply and explore genomic technologies to advance the understanding of biology and improve health. Our ambition is vast – we take on projects that are not possible anywhere else. We use the power of genome sequencing to understand and harness the information in DNA. Funded by Wellcome, we have the freedom and support to push the boundaries of genomics. Our findings are used to improve health and to understand life on Earth.

See more

Latest activity

4 signals

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.